Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer
Ayodeji Olukoya(Georgetown University), Rebecca B. Riggins(Georgetown University)
Cited by 11
Related Papers
Estrogen-related Receptor β (ERRβ) – Renaissance Receptor or Receptor Renaissance?
|Nuclear Receptor Signaling|2016|37
Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancer
|Oncotarget|2016|17
The orphan nuclear receptor estrogen-related receptor beta (ERRβ) in triple-negative breast cancer
|Breast Cancer Research and Treatment|2019|15
Differential prioritization of therapies to subtypes of triple negative breast cancer using a systems medicine method
|Oncotarget|2017|10
Riluzole suppresses growth and enhances response to endocrine therapy in ER+ breast cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2020|4